Last reviewed · How we verify
NCT06205940: RESONATE-CS8
Building Individual and Community Resilience Through Nature-based Therapies - Case Study 8 Nature for All
NA trial testing Audioguided Nature tour in Mobility Disability in 124 participants. Not yet recruiting.
31 October 2024
Quick facts
| Lead sponsor | University of Copenhagen |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 124 |
| Start date | 1 June 2024 |
| Primary completion | 31 October 2024 |
| Estimated completion | 30 April 2025 |
Drugs / interventions tested
- Audioguided Nature tour
- Non audio guided nature tour
Conditions studied
- Mobility Disability — all drugs for Mobility Disability →
Sponsor
University of Copenhagen
Who can join
18 and older, any sex, with Mobility Disability. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this randomized controlled trial is to test if digital engagement instructions (a nature guide APP) can enhance the nature connection and provide positive health outcomes for individuals with mobility disabilities. The study has an active control group, that will have the same nature exposure without the guidance of the APP. 124 participants will be randomized to either the intervention group or the control group. The intervention consists of two parts: Intervention day 1: The intervention starts for both the 'intervention group' and the 'control group' in the Hoersholm arboretum, which contain Denmark's largest collection of different trees and shrubs. The intervention group will listen to the 'intervention APP' during a tour with three stops along a trail in the arboretum. The active control group will take the same tour but does not have access to the 'intervention APP'. 4 week intervention: During the following 4 weeks the participants will be encouraged to visit nature for 120 minutes in total per week on their own. The intervention group will still be encouraged to use the APP during the nature visits.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Testing nature-based biopsychosocial resilience theory: a research programme protocol.
White MP, Egger JAM, Amato G, Astell-Burt T, et al · · 2026 · PMID 42032758 · DOI 10.1186/s13690-026-01903-5
Verify or expand the search:
- PubMed search for NCT06205940
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Mobility Disability
Currently open trials in the same condition.
- NCT06940037 — The Impact of Biological Mechanisms of Aging on Response Variability to Resistance Training in Older Adults · NA · recruiting
Other University of Copenhagen trials
Trials by the same sponsor.
- NCT07461324 — Surgeons' Prediction of Dental Surgery Complications and the Influence of Patient Characteristics: Development of an AI · not yet recruiting
- NCT07389421 — School Meals in Denmark · NA · not yet recruiting
- NCT07450690 — Exercise Training Effects on Muscle Function in Adults With Mitochondrial Myopathy · NA · recruiting
- NCT07302880 — The Acute Interference of Biotin in Blood Analysis · NA · not yet recruiting
- NCT07312981 — The CPH-MBD Cohort Dietary Substudy - Comparison of Methods for Dietary Registrations · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06205940 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Copenhagen
- Last refreshed: 17 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06205940.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing